ClinicalTrials.Veeva

Menu

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Cognitive Function

C

Chonbuk National University

Status

Completed

Conditions

Cognitive Function

Treatments

Dietary Supplement: Hydrolysed Red Ginseng Extract
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT04184388
IH-CF-HRGE

Details and patient eligibility

About

This study was the evaluate the efficacy and safety of hydrolysed red ginseng extract on the improvement of Cognitive Function

Full description

This study was 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate. 100 subjects participated in hydrolysed red ginseng extract or placebo group. To evaluate the changes in the evaluation items when hydrolysed red ginseng extract was taken 12 weeks compared with placebo.

Enrollment

100 patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Persons who are at least 60 years of age at screening
  • Persons who have Korean Mini-Mental Status Examination(K-MMSE) result in 25-28 points
  • Persons who agree to voluntary participation and to comply with the Notice after fully hearing and understanding the details of this human trial

Exclusion criteria

  • Patients with a past history of treatment with Axis I disorder in SCID(Structured Clinical Interview for DSM-IV) which is a structured clinical interview in the Diagnostic and Statistical Manual of Mental Disorders at Screening or who have been treated within the last 3 years

  • Patients with BMI(Body Mass Index)<18.5 kg/m^ or 35 kg/m^≤BMI(Body Mass Index)

  • Patients with alcohol abuse or dependence within the last 3 months

  • Patients who have clinically significant following severe illness (i.e., Cardiovascular, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric, musculoskeletal, inflammatory, blood and tumors, gastrointestinal diseases, etc.)

  • Patients with a history of clinically significant hypersensitivity to ginseng or red ginseng

  • Patients taking medicines, health functional foods or herbal medicines related to the improvement of cognitive function and memory within 1 month before screening

  • Patients who ingested ginseng and red ginseng extract's health functional food within 1 month before screening

  • Patients who whole blood donation within 1 months before the first ingestion or Component blood donation within 2 weeks

  • Patients who participate in another human trial within 3 months

  • Those who show the following results in the Laboratory test

    • AST, ALT > 3 times upper limit of the normal range
    • Other significant laboratory test opinion
  • Patients who are deemed unsuitable for participating in the human trial due to other reasons

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups, including a placebo group

Hydrolysed Red Ginseng Extract
Experimental group
Description:
Hydrolysed Red Ginseng extract for 1g/day
Treatment:
Dietary Supplement: Hydrolysed Red Ginseng Extract
Placebo
Placebo Comparator group
Description:
Hydrolysed Red Ginseng extract for 0g/day
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems